Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Healthcare Medical Devices
Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.


TSXV:LBL.H - Post by User

Lattice Biologics Ltd > Video - 3 months ago - Guy Cook gets IV treatment.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(157)
•••
Comment by cleareyeon Jul 29, 2020 7:54am
69 Views
Post# 31335494

RE:RE:Video - 3 months ago - Guy Cook gets IV treatment.

RE:RE:Video - 3 months ago - Guy Cook gets IV treatment.I posted that youtube video, without positive or negative comment.  I was curious about the reaction.  It doesn't look like a presentation that a CEO would allow out into the public. It left me wondering if the company knows what a clinical trial is.

Is Guy Cook so confident that he allows himself to be so (deceptively) casual?

I am still interested in this company for their core business rather than their clinic trials for therapies associated with COVID 19 or Psoriasis, at least until they update me with positive trial news along with a concrete path forward.

I hope to hear an update on how their core business has recovered after the most severe aspects of the lockdown are over.

I presume that they will give a quarterly update before Labour Day. Will the MD&A be informative?

They may also give an update on the COVID 19 and the Psoriasis related trials. PLEASE!

All these updates would be very appropriate. We really are left in the dark, thinking the worst.

cleareye.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities